Cargando…

Enhanced therapeutic effects of mesenchymal stem cell-derived extracellular vesicles within chitosan hydrogel in the treatment of diabetic foot ulcers

Extracellular vesicles (EVs) derived from human umbilical cord mesenchymal stem cells (hUCMSCs) have emerged as promising candidates for cell-free therapy in various diseases, including chronic cutaneous wounds. However, the lack of standardized protocols for EVs’ preparation and identification pose...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shuangshuang, Chen, Siyu, Zhang, Chengpeng, Han, Jing, Lin, Chunyuan, Zhao, Xiaohui, Guo, Huizhen, Tan, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462522/
https://www.ncbi.nlm.nih.gov/pubmed/37639051
http://dx.doi.org/10.1007/s10856-023-06746-y
_version_ 1785098050853666816
author Yang, Shuangshuang
Chen, Siyu
Zhang, Chengpeng
Han, Jing
Lin, Chunyuan
Zhao, Xiaohui
Guo, Huizhen
Tan, Yi
author_facet Yang, Shuangshuang
Chen, Siyu
Zhang, Chengpeng
Han, Jing
Lin, Chunyuan
Zhao, Xiaohui
Guo, Huizhen
Tan, Yi
author_sort Yang, Shuangshuang
collection PubMed
description Extracellular vesicles (EVs) derived from human umbilical cord mesenchymal stem cells (hUCMSCs) have emerged as promising candidates for cell-free therapy in various diseases, including chronic cutaneous wounds. However, the lack of standardized protocols for EVs’ preparation and identification poses a significant challenge to their clinical application. Thus, the objective was to develop a safe and efficient method for the large-scale production of hUCMSC-derived EVs while establishing a comprehensive identification protocol encompassing morphology, particle size distribution, protein expression, and purity. This study observed that most of the EVs acquired through the protocol exhibited either a cup-shaped or round-shaped structure, with a median diameter of ~73.25 nm. The proportions of EVs positive for CD9, CD63, and CD81 were 37.5%, 38.6%, and 19.8%, respectively. To enhance their therapeutic potential in wound treatment, EVs were incorporated into chitosan hydrogel, forming chitosan hydrogel-EVs (CS-EVs). Furthermore, it was demonstrated that CS-EVs exhibited continuous release of EVs into the surrounding environment and, importantly, that the released EVs were internalized by human umbilical vein endothelial cells (HUVECs), resulting in significant enhancement of cell migration and angiogenesis. Additionally, in a rat model of diabetic foot ulcers, CS-EVs demonstrated a robust therapeutic effect in promoting wound healing. Following a 15-day treatment period, the group treated with CS-EVs demonstrated an impressive 93.3% wound closure ability, accompanied by a high degree of re-epithelialization. In contrast, the control group exhibited only a 71.5% reduction in wound size. In summary, this study offers solutions for the purification, characterization, and application of EVs in clinical wound treatment. These results not only offer fresh perspectives on the involvement of hUCMSC-derived EVs in wound healing but also introduce a non-invasive approach for applying EVs that holds practical significance in skin repair. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-10462522
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-104625222023-08-30 Enhanced therapeutic effects of mesenchymal stem cell-derived extracellular vesicles within chitosan hydrogel in the treatment of diabetic foot ulcers Yang, Shuangshuang Chen, Siyu Zhang, Chengpeng Han, Jing Lin, Chunyuan Zhao, Xiaohui Guo, Huizhen Tan, Yi J Mater Sci Mater Med Tissue Engineering Constructs and Cell Substrates Extracellular vesicles (EVs) derived from human umbilical cord mesenchymal stem cells (hUCMSCs) have emerged as promising candidates for cell-free therapy in various diseases, including chronic cutaneous wounds. However, the lack of standardized protocols for EVs’ preparation and identification poses a significant challenge to their clinical application. Thus, the objective was to develop a safe and efficient method for the large-scale production of hUCMSC-derived EVs while establishing a comprehensive identification protocol encompassing morphology, particle size distribution, protein expression, and purity. This study observed that most of the EVs acquired through the protocol exhibited either a cup-shaped or round-shaped structure, with a median diameter of ~73.25 nm. The proportions of EVs positive for CD9, CD63, and CD81 were 37.5%, 38.6%, and 19.8%, respectively. To enhance their therapeutic potential in wound treatment, EVs were incorporated into chitosan hydrogel, forming chitosan hydrogel-EVs (CS-EVs). Furthermore, it was demonstrated that CS-EVs exhibited continuous release of EVs into the surrounding environment and, importantly, that the released EVs were internalized by human umbilical vein endothelial cells (HUVECs), resulting in significant enhancement of cell migration and angiogenesis. Additionally, in a rat model of diabetic foot ulcers, CS-EVs demonstrated a robust therapeutic effect in promoting wound healing. Following a 15-day treatment period, the group treated with CS-EVs demonstrated an impressive 93.3% wound closure ability, accompanied by a high degree of re-epithelialization. In contrast, the control group exhibited only a 71.5% reduction in wound size. In summary, this study offers solutions for the purification, characterization, and application of EVs in clinical wound treatment. These results not only offer fresh perspectives on the involvement of hUCMSC-derived EVs in wound healing but also introduce a non-invasive approach for applying EVs that holds practical significance in skin repair. GRAPHICAL ABSTRACT: [Image: see text] Springer US 2023-08-28 2023 /pmc/articles/PMC10462522/ /pubmed/37639051 http://dx.doi.org/10.1007/s10856-023-06746-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Tissue Engineering Constructs and Cell Substrates
Yang, Shuangshuang
Chen, Siyu
Zhang, Chengpeng
Han, Jing
Lin, Chunyuan
Zhao, Xiaohui
Guo, Huizhen
Tan, Yi
Enhanced therapeutic effects of mesenchymal stem cell-derived extracellular vesicles within chitosan hydrogel in the treatment of diabetic foot ulcers
title Enhanced therapeutic effects of mesenchymal stem cell-derived extracellular vesicles within chitosan hydrogel in the treatment of diabetic foot ulcers
title_full Enhanced therapeutic effects of mesenchymal stem cell-derived extracellular vesicles within chitosan hydrogel in the treatment of diabetic foot ulcers
title_fullStr Enhanced therapeutic effects of mesenchymal stem cell-derived extracellular vesicles within chitosan hydrogel in the treatment of diabetic foot ulcers
title_full_unstemmed Enhanced therapeutic effects of mesenchymal stem cell-derived extracellular vesicles within chitosan hydrogel in the treatment of diabetic foot ulcers
title_short Enhanced therapeutic effects of mesenchymal stem cell-derived extracellular vesicles within chitosan hydrogel in the treatment of diabetic foot ulcers
title_sort enhanced therapeutic effects of mesenchymal stem cell-derived extracellular vesicles within chitosan hydrogel in the treatment of diabetic foot ulcers
topic Tissue Engineering Constructs and Cell Substrates
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462522/
https://www.ncbi.nlm.nih.gov/pubmed/37639051
http://dx.doi.org/10.1007/s10856-023-06746-y
work_keys_str_mv AT yangshuangshuang enhancedtherapeuticeffectsofmesenchymalstemcellderivedextracellularvesicleswithinchitosanhydrogelinthetreatmentofdiabeticfootulcers
AT chensiyu enhancedtherapeuticeffectsofmesenchymalstemcellderivedextracellularvesicleswithinchitosanhydrogelinthetreatmentofdiabeticfootulcers
AT zhangchengpeng enhancedtherapeuticeffectsofmesenchymalstemcellderivedextracellularvesicleswithinchitosanhydrogelinthetreatmentofdiabeticfootulcers
AT hanjing enhancedtherapeuticeffectsofmesenchymalstemcellderivedextracellularvesicleswithinchitosanhydrogelinthetreatmentofdiabeticfootulcers
AT linchunyuan enhancedtherapeuticeffectsofmesenchymalstemcellderivedextracellularvesicleswithinchitosanhydrogelinthetreatmentofdiabeticfootulcers
AT zhaoxiaohui enhancedtherapeuticeffectsofmesenchymalstemcellderivedextracellularvesicleswithinchitosanhydrogelinthetreatmentofdiabeticfootulcers
AT guohuizhen enhancedtherapeuticeffectsofmesenchymalstemcellderivedextracellularvesicleswithinchitosanhydrogelinthetreatmentofdiabeticfootulcers
AT tanyi enhancedtherapeuticeffectsofmesenchymalstemcellderivedextracellularvesicleswithinchitosanhydrogelinthetreatmentofdiabeticfootulcers